Evidence map›Paper›PMID 42495331›Full record

ReviewACS omega2026

Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.

Mlis Belete, Yadessa Melaku, Endale Mulugeta

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mlis BeleteDepartment of Applied Chemistry, College of Applied Natural Science, Adama Science and Technology University, 1888 Adama, Ethiopia.ORCID https://orcid.org/0000-0002-3049-6065
Yadessa MelakuDepartment of Applied Chemistry, College of Applied Natural Science, Adama Science and Technology University, 1888 Adama, Ethiopia.ORCID https://orcid.org/0000-0003-2599-0517
Endale MulugetaDepartment of Applied Chemistry, College of Applied Natural Science, Adama Science and Technology University, 1888 Adama, Ethiopia.ORCID https://orcid.org/0000-0002-2869-0934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrimidine-based molecular hybrids have emerged as a privileged class of bioactive scaffolds owing to their structural versatility and broad pharmacological potential. This review comprehensively covers recent advances in green synthetic strategies, including solvent-free, microwave-assisted, ultrasound-assisted, ionic liquid-mediated, and nanocatalyst-promoted Biginelli-type reactions, synthesis, and the biological applications of pyrimidine hybrids incorporating pharmacophores such as chalcones, quinolines, triazoles, pyrazoles, and coumarins. These hybrids demonstrate potent antibacterial, antifungal, anticancer, anti-inflammatory, and antiprotozoal activities through mechanisms including kinase inhibition, apoptosis induction, COX-2 selectivity, and NF-κB/MAPK modulation. Structure-activity relationship analysis highlights the critical influence of substituent electronic properties, substitution position, and linker design on biological potency and selectivity. Current challenges, including poor solubility and metabolic instability, are discussed alongside future directions emphasizing computational drug design, target expansion, and clinical translation.

Identifiers

PMID42495331
PMCPMC13393030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.